Summit Therapeutics Inc. vs Johnson & Johnson
SMMT vs JNJ — side-by-side comparison from reported financials. SMMT leads 1, JNJ leads 4 of 5 comparable metrics.
Summit Therapeutics Inc.
SMMT · Healthcare
$17.55+2.21%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | SMMT | JNJ |
|---|---|---|
| Price | $17.55 | $261.79 |
| Market cap | $14.0B | $631B |
| Revenue (TTM) | — | $97.9B |
| Revenue growth | — | +5.6% |
| Net margin | — | 21.5% |
| Free cash flow | -$932M | $22.2B |
| Net cash (debt) | $670M | ($27.8B) |
| 1-year price return | -22.5% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | — | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -169% | 26% |
| CV checks passed | 3 of 8 | 10 of 8 |
| Employees | 265 | 140,800 |
Full résumé-style profiles: SMMT CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.